Cargando…

Ex vivo assays to predict enhanced chemosensitization by hyperthermia in urothelial cancer of the bladder

INTRODUCTION: Bladder cancer (urothelial carcinoma) is a common malignancy characterized by high recurrence rates and intense clinical follow-up, indicating the necessity for more effective therapies. Current treatment regimens include intra-vesical administration of mitomycin C (MMC) for non-muscle...

Descripción completa

Detalles Bibliográficos
Autores principales:	van den Tempel, Nathalie, Naipal, Kishan A. T., Raams, Anja, van Gent, Dik C., Franckena, Martine, Boormans, Joost L., Kanaar, Roland
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6294360/ https://www.ncbi.nlm.nih.gov/pubmed/30550547 http://dx.doi.org/10.1371/journal.pone.0209101

Ejemplares similares

Attenuated XPC Expression Is Not Associated with Impaired DNA Repair in Bladder Cancer
por: Naipal, Kishan A. T., et al.
Publicado: (2015)

The effect of thermal dose on hyperthermia-mediated inhibition of DNA repair through homologous recombination
por: van den Tempel, Nathalie, et al.
Publicado: (2017)

Ex vivo tumor culture systems for functional drug testing and therapy response prediction
por: Meijer, Titia G, et al.
Publicado: (2017)

Exploiting DNA repair defects for novel cancer therapies
por: van Gent, Dik C., et al.
Publicado: (2016)

On the Mechanism of Hyperthermia-Induced BRCA2 Protein Degradation
por: van den Tempel, Nathalie, et al.
Publicado: (2019)

Tumor slice culture system to assess drug response of primary breast cancer
por: Naipal, Kishan A. T., et al.
Publicado: (2016)

Boosting the effects of hyperthermia-based anticancer treatments by HSP90 inhibition
por: Vriend, Lianne E.M., et al.
Publicado: (2017)

Ex vivo treatment of prostate tumor tissue recapitulates in vivo therapy response
por: Zhang, Wenhao, et al.
Publicado: (2018)

Functional Ex Vivo Tissue-Based Chemotherapy Sensitivity Testing for Breast Cancer
por: Ladan, Marjolijn M., et al.
Publicado: (2022)

Clinical Performance and Future Potential of Magnetic Resonance Thermometry in Hyperthermia
por: Feddersen, Theresa V., et al.
Publicado: (2020)

Commentary: The Impact of the Time Interval Between Radiation and Hyperthermia on Clinical Outcome in Patients With Locally Advanced Cervical Cancer
por: Kroesen, Michiel, et al.
Publicado: (2019)

PD-L1 expression in urothelial bladder cancer varies more among specimen types than between companion assays
por: de Jong, Joep J., et al.
Publicado: (2021)

The clonal relation of primary upper urinary tract urothelial carcinoma and paired urothelial carcinoma of the bladder
por: van Doeveren, Thomas, et al.
Publicado: (2020)

Induction therapy with ipilimumab and nivolumab followed by consolidative chemoradiation as organ-sparing treatment in urothelial bladder cancer: study protocol of the INDIBLADE trial
por: Stockem, C.F., et al.
Publicado: (2023)

Impact of Number of Segmented Tissues on SAR Prediction Accuracy in Deep Pelvic Hyperthermia Treatment Planning
por: VilasBoas-Ribeiro, Iva, et al.
Publicado: (2020)

MR Thermometry Accuracy and Prospective Imaging-Based Patient Selection in MR-Guided Hyperthermia Treatment for Locally Advanced Cervical Cancer
por: VilasBoas-Ribeiro, Iva, et al.
Publicado: (2021)

Proof-of-concept study linking ex vivo sensitivity testing to neoadjuvant anthracycline-based chemotherapy response in breast cancer patients
por: Ladan, Marjolijn M., et al.
Publicado: (2023)

Low dose ionizing radiation strongly stimulates insertional mutagenesis in a γH2AX dependent manner
por: Zelensky, Alex N., et al.
Publicado: (2020)

Nkx2.8 promotes chemosensitivity in bladder urothelial carcinoma via transcriptional repression of MDR1
por: Zhou, Zhaohui, et al.
Publicado: (2022)

A Multicenter Retrospective Cohort Series of Muscle-invasive Bladder Cancer Patients Treated with Definitive Concurrent Chemoradiotherapy in Daily Practice
por: de Ruiter, Ben-Max, et al.
Publicado: (2022)

ATR-Chk1 signaling inhibition as a therapeutic strategy to enhance cisplatin chemosensitivity in urothelial bladder cancer
por: Li, Ching-Chia, et al.
Publicado: (2015)

Modulating the Heat Stress Response to Improve Hyperthermia-Based Anticancer Treatments
por: Scutigliani, Enzo M., et al.
Publicado: (2021)

Feasibility, SAR Distribution, and Clinical Outcome upon Reirradiation and Deep Hyperthermia Using the Hypercollar3D in Head and Neck Cancer Patients
por: Kroesen, Michiel, et al.
Publicado: (2021)

Augmentation in Chemosensitivity of Intratumor Quiescent Cells by Combined Treatment with Nicotinamide and Mild Hyperthermia
por: Masunaga, Shin‐ichiro, et al.
Publicado: (1997)

Limited Funds for Bladder Cancer Research and What Can We Do About It
por: Boormans, Joost L., et al.
Publicado: (2016)

POD–Kalman filtering for improving noninvasive 3D temperature monitoring in MR‐guided hyperthermia
por: VilasBoas‐Ribeiro, Iva, et al.
Publicado: (2022)

Rising incidence rates and unaltered survival rates for primary upper urinary tract urothelial carcinoma: a Dutch population‐based study from 1993 to 2017
por: van Doeveren, Thomas, et al.
Publicado: (2021)

Knockdown of HMGN5 increases the chemosensitivity of human urothelial bladder cancer cells to cisplatin by targeting PI3K/Akt signaling
por: Gan, Yu, et al.
Publicado: (2017)

Real time ex vivo chemosensitivity assay for pancreatic adenocarcinoma
por: Kim, Dae Won, et al.
Publicado: (2023)

Comparison of High- and Low-LET Radiation-Induced DNA Double-Strand Break Processing in Living Cells
por: Roobol, Stefan J., et al.
Publicado: (2020)

Reduce bladder cancer recurrence in patients treated for upper urinary tract urothelial carcinoma: The REBACARE-trial
por: van Doeveren, T., et al.
Publicado: (2018)

Tropomyosins: Potential Biomarkers for Urothelial Bladder Cancer
por: Humayun-Zakaria, Nada, et al.
Publicado: (2019)

HSF2BP negatively regulates homologous recombination in DNA interstrand crosslink repair
por: Sato, Koichi, et al.
Publicado: (2020)

Investigation of Particle Accumulation, Chemosensitivity and Thermosensitivity for Effective Solid Tumor Therapy Using Thermosensitive Liposomes and Hyperthermia
por: Lokerse, Wouter J.M., et al.
Publicado: (2016)

Down-staging (<pT2) of urothelial cancer at cystectomy after the diagnosis of detrusor muscle invasion (pT2) at diagnostic transurethral resection (TUR): is prediction possible?
por: Beukers, Willemien, et al.
Publicado: (2012)

Bladder Cancer Chemosensitivity Is Affected by Paraoxonase-2 Expression
por: Fumarola, Stefania, et al.
Publicado: (2020)

Hyperthermia as Adjunct to Intravesical Chemotherapy for Bladder Cancer
por: Owusu, Richmond A., et al.
Publicado: (2013)

Evolution of Urothelial Bladder Cancer in the Context of Molecular Classifications
por: Minoli, Martina, et al.
Publicado: (2020)

Prospective bladder cancer infrastructure for experimental and observational research on bladder cancer: study protocol for the ‘trials within cohorts’ study ProBCI
por: Richters, Anke, et al.
Publicado: (2021)

Toward Better Predictions of Chemosensitivity: Comparative Study of Conventional and Simulated Chemosensitivity Tests for Bladder Cancer Cell Lines
por: Kim, Taek Sang, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_c16v9s409on70qcm7kr9305h6f